Kinetics and structure of a cold-adapted hetero-octameric ATP phosphoribosyltransferase by Stroek, Rozanne et al.
1 
 
Kinetics and structure of a cold-adapted hetero-octameric ATP phosphoribosyltransferase† 
 
Rozanne Stroek,‡,§,£ Ying Ge,¥,£ Paul D. Talbot,‡ Mateusz K. Glok,‡ Klaudia E. Bernaś,¥ 
Catherine M. Thomson,‡ Eoin R. Gould,¥ Magnus S. Alphey,¥,‡ Huanting Liu,¥ Gordon J. 
Florence,¥ James H. Naismith,¥ and Rafael G. da Silva‡,* 
 
‡School of Biology and ¥School of Chemistry, Biomedical Sciences Research Complex, 
University of St Andrews, North Haugh, St Andrews, Fife UK KY16 9ST 
§Rotterdam University of Applied Science, School of Engineering and Applied Science, G. J. 
de Jonghweg 4-6, 3015 GG, Rotterdam, The Netherlands 
 
£These authors contributed equally to this work. 
 
†This work was supported by the University of St Andrews, and a Leverhulme Trust grant (RL-
2012-025) to G.J.F. RS was the recipient of an Erasmus Undergraduate Fellowship.  
 
*To whom correspondence should be addressed: rgds@st-andrews.ac.uk, phone: +44 01334 
463496. 
 
Running title: Kinetics and structure of P. arcticus ATPPRT 
2 
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magnetic resonance; CD, circular dichroism; HEPES, 4-(2-hydroxyethyl)-piperazine-1-
ethanesulfonic acid; DTT, dithiothreitol; PaHisGS, P. arcticus HisGS; PaHisZ, P. arcticus 
HisZ; IPTG, isopropyl-β-D-1-thiogalactopyranoside; LB, Lysogeny broth; TEVP, tobacco etch 
virus protease; MtPPase, Mycobacterium tuberculosis inorganic pyrophosphatase; CV, column 
volumes; MWCO, molecular weight cut off; ESI-MS, electrospray ionisation mass 
spectrometry; KD, equilibrium dissociation constant; EcATPPRT, E. coli ATPPRT; rmsd, root-
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Abstract: ATP-phosphoribosyltransferase (ATPPRT) catalyses the first step in histidine 
biosynthesis, the condensation of ATP and 5-phospho--D-ribosyl-1-pyrophosphate to 
generate N1-(5-phospho--D-ribosyl)-ATP and inorganic pyrophosphate. The enzyme is 
allosterically inhibited by histidine. Two forms of ATPPRT, encoded by the hisG gene, exist 
in nature, depending on the species. The long form, HisGL, is a single polypeptide chain with 
catalytic and regulatory domains. The short form, HisGS, lacks a regulatory domain, and cannot 
bind histidine. HisGS instead is found in complex with a regulatory protein, HisZ, constituting 
the ATPPRT holoenzyme. HisZ triggers HisGS catalytic activity while rendering it sensitive to 
allosteric inhibition by histidine. Until recently, HisGS was thought to be catalytically inactive 
without HisZ. Here, recombinant HisGS and HisZ from the psychrophilic bacterium 
Psychrobacter arcticus were independently overexpressed and purified. The crystal structure 
of P. arcticus ATPPRT was solved at 2.34-Å resolution, revealing an equimolar HisGS-HisZ 
hetero-octamer. Steady-state kinetics indicate that both ATPPRT holoenzyme and HisGS are 
catalytically active. Surprisingly, HisZ confers only a modest 2- to 4-fold increase in kcat. 
Reaction profiles for both enzymes are indistinguishable by 31P-NMR, indicating that the same 
reaction is catalysed. Temperature dependence of kcat shows deviation from Arrhenius 
behaviour at 308 K with the holoenzyme. Interestingly, such deviation is detected only at 313 
K with HisGS. Thermal denaturation by CD spectroscopy resulted in Tm’s of 312 K and 316 K 
for HisZ and HisGS, respectively, suggesting that HisZ renders the ATPPRT complex more 
thermolabile. This is the first characterisation of a psychrophilic ATPPRT.  
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 Adenosine 5ʹ-triphosphate phosphoribosyltransferase (ATPPRT) (EC 2.4.2.17) 
catalyses the reversible Mg2+-dependent reaction between adenosine 5ʹ-triphosphate (ATP) and 
5-phospho--D-ribosyl-1-pyrophosphate (PRPP) to yield N1-(5-phospho--D-ribosyl)-ATP 
(PR-ATP) and inorganic pyrophosphate (PPi) (Scheme 1), the first step in histidine 
biosynthesis.1 The chemical equilibrium of the reaction strongly favours reactants,2 and the 
enzyme is allosterically inhibited by histidine.1 In addition to being a model for understanding 
allostery,2-4 ATPPRT is of biotechnological interest as a tool for histidine production, provided 
that histidine feedback inhibition can be overcome.5-7 
Two forms of ATPPRT, encoded by the hisG gene, are found in nature. Fungi, plants, 
and most bacteria possess a long, homo-hexameric protein, HisGL, each subunit consisting of 
two domains that make up the catalytic core and a C-terminal regulatory domain that mediates 
feedback inhibition by histidine.8 Some bacteria and archaea have a short version of the protein, 
HisGS, which lacks the C-terminal regulatory domain and is insensitive to histidine. In these 
organisms, a catalytically inactive regulatory protein, HisZ, the product of the hisZ gene, is 
present.9 HisZ, which shares a common ancestry with histidyl-tRNA synthetase (HisRS), binds 
HisGS to form the hetero-octameric ATPPRT holoenzyme and activates HisGS catalysis.
10, 11 
Furthermore, HisZ binds histidine to allosterically inhibit the holoenzyme.11, 12  
While much is known about the mechanism,13-18 structure,4, 8, 19, 20 and regulation3-7, 15 
of HisGL-type ATPPRT’s from several organisms, limited information is available on HisGS-
HisZ-type ATPPRT’s, with the enzymes of only two species, the mesophilic bacterium 
Lactococcus lactis (LlATPPRT),10, 11, 21 and the thermophile Thermotoga maritima 
(TmATPPRT),12 being reported. Only recently was it demonstrated, contrary to previous 
assumption, that L. lactis HisGS (LlHisGS) retains some catalytic activity in the absence of L. 
lactis HisZ (LlHisZ).22 Likewise, while mesophilic and thermophilic ATPPRT’s have been 
characterised,11, 12 no psychrophilic example has been reported.  
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Psychrophilic enzymes have maximum activities at lower temperatures than those of 
their mesophilic and thermophilic counterparts, and also present higher protein flexibility.23-26 
Thought to be an adaptation to support catalysis at low temperature, this increased flexibility 
also results in thermolabile proteins that tend to unfold at relatively mild temperatures.27, 28 
Owing to their peculiar properties, investigations of cold-adapted enzymes have an impact on 
physical chemistry,25, 26, 29 biotechnology,30, 31 and even astrobiology.32, 33 
In the present work, the first characterisation of a psychrophilic ATPPRT is described. 
Recombinant HisGS and HisZ from the Siberian permafrost bacterium Psychrobacter arcticus, 
which naturally grows at temperatures between 10 and 0 °C,34 were overexpressed and 
purified, and X-ray crystallography, steady-state kinetics, and 31P-nuclear magnetic resonance 
(31P-NMR) and circular dichroism (CD) spectroscopies were employed to investigate the 
structural, catalytic, and temperature-dependent properties of P. arcticus ATPPRT 
(PaATPRT). The initialism PaATPPRT henceforth refers to the holoenzyme consisting of the 
complex between catalytic and regulatory subunits.  
EXPERIMENTAL PROCEDURES 
 Materials. ATP, PRPP, Glutaraldehyde, deuterium oxide (99.9 atom % deuterium), 4-
(2-hydroxyethyl)-piperazine-1-ethanesulfonic acid (HEPES), tricine, dithiothreitol (DTT), 
imidazole, glycerol, lysozyme, DNAse I, ampicillin, kanamycin, and chloramphenicol were 
purchased from Sigma-Aldrich. EDTA-free Cømplete protease inhibitor cocktail was from 
Roche. Isopropyl-β-D-1-thiogalactopyranoside (IPTG) were purchased from Fisher Scientific. 
All other chemicals were purchased from readily available commercial sources, and all 
chemicals were used without further purification.  
 Expression of P. arcticus HisGS (PaHisGS) and P. arcticus HisZ (PaHisZ). The 
expression vectors pJexpress431 and pJexpress414 containing the DNA sequences encoding 
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for PaHisGS and PaHisZ, respectively, each with a tobacco etch virus protease (TEVP)-
cleavable N-terminal His-tag-encoding sequence, all codon-optimized for heterologous 
expression in Escherichia coli, were obtained from DNA 2.0, Inc. The expression construct for 
PaHisGS was transformed into E. coli C43(DE3) competent cells (Sigma-Aldrich), whereas 
that for PaHisZ, into E. coli BL21(DE3) competent cells (Novagen). Transformed cells were 
grown independently in lysogeny broth (LB), containing either 50 g mL-1 kanamycin (for 
PaHisGS expression) or 100g mL-1 ampicillin (for PaHisZ expression), at 37 °C to an 
OD600nm of 0.8. The cultures were then equilibrated to 16 °C and expression was induced with 
1 mM IPTG. Cells were allowed to grow for an additional 20-h period at 16 °C, then harvested 
by centrifugation at 6,774 g for 15 min and stored at 20 °C. 
 Expression of TEVP and Mycobacterium tuberculosis inorganic pyrophosphatase 
(MtPPase). The expression vector pRK793 harbouring the coding sequence for an N-terminal 
His-tagged S219V-TEVP was transformed into E. coli Rosetta(DE3) competent cells 
(Novagen) and TEVP was expressed as previously published.35 The expression vector 
pJexpress411 harbouring the coding sequence for an N-terminal His-tagged MtPPase (a kind 
gift from Dr Luiz Pedro S. de Carvalho, The Francis Crick Institute) was transformed into E. 
coli BL21(DE3) and expressed as previously described.3 
 Purification of PaHisGS and PaHisZ. Each recombinant protein was purified separately 
from the other, and all purification procedures were carried out at 4 °C. All chromatographic 
steps employed an AKTA Start FPLC system (GE Lifesciences). Cells were allowed to thaw 
on ice for 20 min before being re-suspended in buffer A (50 mM HEPES, 10 mM imidazole, 
500 mM NaCl, pH 8.0) containing 0.2 mg mL-1 lysozyme, 0.05 mg mL-1 DNAse I, and half a 
tablet of EDTA-free Cømplete protease inhibitor cocktail, disrupted in a high pressure cell 
disruptor (Constant Systems), and centrifuged at 48,000 g for 30 min to remove cell debris. 
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The supernatants were filtered through 0.45 m membranes and loaded onto a HisTrap FF 5 
mL column (GE Healthcare) pre-equilibrated with buffer A. The column was washed with 10 
column volumes (CV) of buffer A, and the adsorbed proteins were eluted with 20 CV of a 
linear gradient of 0% to 60% buffer B (50 mM HEPES, 500 mM imidazole, 500 mM NaCl, pH 
8.0). Fractions containing the desired protein were pooled, mixed with TEVP at a ratio of either 
1 mg of TEVP to 10 mg of PaHisGS or 1.5 mg of TEVP to 10 mg of PaHisZ, and dialysed 
twice against 2 L of buffer C (20 mM HEPES, 150 mM NaCl, 2 mM DTT, 10% glycerol, pH 
7.5) then once against 2 L of buffer A. Samples were filtered through 0.45 m membranes and 
loaded onto a HisTrap FF 5 mL column (GE Healthcare) pre-equilibrated with buffer A. The 
flow through was collected and analysed by SDS-PAGE (NuPAGE Bis-Tris 4-12% Pre-cast 
gels, ThermoFisher Scientific), concentrated using 10,000 molecular weight cut off (MWCO) 
ultrafiltration membranes (Millipore), dialysed twice against 2 L of 20 mM HEPES pH 8.0, 
aliquoted, and stored at 80 °C. Concentrations of PaHisGS and PaHisZ were determined 
spectrophotometrically (NanoDrop) at 280 nm using theoretical extinction coefficients (280nm) 
of 8,940 M-1 cm-1 and 25,900 M-1 cm-1, respectively. Each protein’s molecular mass was 
determined by electrospray ionisation mass spectrometry (ESI-MS).  
Purification of TEVP and MtPPase. All purification steps were carried out at 4 °C, and 
all chromatographic steps employed an AKTA Start FPLC system. TEVP was prepared as 
previously published35 and stored at 80 °C. MtPPase was purified in the same manner as 
PaHisHS and PaHisZ up to and including the first HisTrap FF 5 mL column. Fractions 
containing MtPPase were pooled, concentrated using a 10,000 MWCO ultrafiltration 
membranes and loaded onto a HiPrep 26/60 Sephacryl S-300 HR column pre-equilibrated with 
20 mM HEPES pH 8.0. MtPPase was eluted with 1 CV of 20 mM HEPES pH 8.0, analysed by 
SDS-PAGE, concentrated using a 10,000 MWCO ultrafiltration membrane, aliquoted, and 
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stored at 80 °C. MtPPase concentration was determined spectrophotometrically at 280 nm 
using an 280nm of 19,940 M-1 cm-1. 
Crystallisation of PaATPPRT. Initial sparse matrix crystallisation screening was 
performed in 96-well Intelli-Plates using a Gryphon crystallization robot (Art Robbins 
Instruments), and hits visualized on a Rigaku Minstrel HT UV. The initial hit (15.73% PEG 
3350, 0.1 M bicine pH 8.5, 0.12 M CaCl2, and 2.16% 1,6-hexanediol) was optimized to 11% 
PEG 3350, 0.1 M bicine pH 8.5, 0.15 M SrCl2, 0.15 M KBr, and 2% 1,6-hexanediol. PaHisGS 
and PaHisZ were mixed in 1:1 molar ratio, the buffer was exchanged to 0.02 M Tris pH 7.0, 
0.05 M KCl, 0.01 M MgCl2, 2 mM DTT, 0.5 mM histidine, and 10 mM ATP. PaATPPRT was 
concentrated to 8 mg mL-1. Using the hanging-drop vapour-diffusion method in 24-well plates 
with protein and precipitant mixed in a 1:1 ratio, crystals (0.3 mm x 0.1 mm x 0.1 mm) grew 
for 21 days at 277 K. 
X-ray data collection and processing. Crystals were cross-linked by vapour diffusion 
with 25% (v/v) aqueous solution of glutaraldehyde for 1 h prior to being cryoprotected in 15% 
2,4-methylpentanediol freshly prepared in reservoir solution, then flash-cooled in liquid 
nitrogen. Diffraction data were collected on a Rigaku 007 MM HFM generator with a Saturn 
944+ CCD detector. Data were processed with iMosflm36 and scaled with Aimless.37 Matthews 
coefficient38 calculations indicated that the asymmetric unit contained an equimolar hetero-
octamer. The structure was solved using molecular replacement as implemented in Phaser39 
and a combination of three sets of deposited coordinates as search models: PDP ID’s 1Z7M 
(LlATPPRT),40 2VD2 (B. subtilis HisG, unpublished), and 3OD1 (B. halodurans, 
unpublished). CCP4 Buccaneer41, 42  was used to assign the majority of correct side chains to 
the PaATPPRT model. Missing side chains and residues were added with COOT43 and the 
model refined with Refmac.44 Secondary structures were assigned with STRIDE.45 Inter-
subunit interface parameters were calculated with PISA.46  
9 
 
PaATPPRT and PaHisGS activity assays. All assays were performed under initial rate 
conditions in the forward direction in 100 mM tricine pH 8.5, 15 mM MgCl2, 100 mM KCl, 4 
mM DTT, and 10 M MtPPase, at different constant temperatures, unless otherwise stated. 
MtPPase irreversibly hydrolyses PPi into two equivalents of inorganic phosphate, overcoming 
the unfavourable reaction equilibrium. Reaction (500 L) rates were measured in a Shimadzu 
spectrophotometer by monitoring the increase in absorbance at 290 nm due to formation of PR-
ATP (290nm = 3,600 M-1 cm-1)17 in 1-cm path length quartz cuvettes (Hellma). A typical 
reaction mixture contained 3 mM ATP, 2 mM PRPP, 1 M PaHisGS in the presence or absence 
of 32 M PaHisZ. Inhibition was tested by running the reaction in the presence of 1 mM 
histidine. Reactions were started by addition of PRPP. Control reactions lacked either ATP, 
PRPP, PaHisGS, or PaHisZ. Background rates in the absence of PaHisZ were subtracted from 
PaATPPRT rates. All kinetic measurements were performed in duplicates.  
Measurement of PaATPPRT equilibrium dissociation constant (KD). Initial velocities 
were measured in the presence of 3 mM ATP, 2 mM PRPP, 1 M PaHisGS, and varying 
concentrations of PaHisZ (2 – 32 M), at different temperatures (283 – 308 K). Reaction 
mixtures were incubated at each temperature for 5 min prior to addition of PRPP to start the 
reaction. PaHisZ-PaHisGS KD values were obtained by fitting initial rate data to a kinetic 
equation (vide infra). 
PaATPPRT and PaHisGS substrate saturation curves. PaATPPRT initial rates were 
measured at various temperatures (283 – 308 K) in the presence of 1.1 M PaHisGS, 20 M 
PaHisZ, saturating concentrations of one substrate, and varying concentrations of the other, 
either ATP (0.4 – 5.6 mM) or PRPP (0.1 – 2.0 mM, 283 – 293 K; 0.2 – 4.0 mM, 298 – 308 K). 
Initial rates for PaHisGS at various temperatures (283 – 313 K) were determined in the presence 
of 2.2 M PaHisGS, saturating concentrations of one substrate, and varying concentrations of 
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the other, either ATP (0.2 – 2.8 mM, 283 – 298 K; 0.4 – 5.6 mM, 303 – 313 K) or PRPP (0.1 
– 2.0 mM, 283 – 298 K; 0.2 – 4.0 mM, 303 – 313 K). Reaction mixtures were incubated at each 
temperature for 5 min prior to addition of PRPP to start the reaction. 
Comparison of PaHisGS and PaATPPRT reactions by 
31P-NMR spectroscopy. 
Reactions (500 L) contained 100 mM tricine pH 8.5, 15 mM MgCl2, 100 mM KCl, 4 mM 
DTT, and 20 M MtPPase, 3 mM ATP, 3 mM PRPP, and either 44 M PaHisGS (for PaHisGS 
reactions) or 22 M PaHisGS and 50 M PaHisZ (for PaATPPRT reactions). Control reactions 
contained all but PaHisGS. Individual standards contained either 3 mM ATP, 3 mM PRPP, or 
3 mM phosphate in 100 mM tricine pH 8.5, 15 mM MgCl2, 100 mM KCl, 4 mM DTT, and 20 
M MtPPase. All reactions were run in duplicates. Samples were incubated for 40 min at 293 
K, after which 100 L of D2O was added to each sample, and proteins were removed by passage 
through 10,000 MWCO Vivaspin centrifugal concentrators. 1H-decoupled 31P-NMR spectra 
were recorded on a Bruker Avance 500 (200 MHz 31P) spectrometer using water as solvent and 
D2O to achieve solvent lock. A total of 128 scans were collected and averaged for each sample, 
with 3 s of relaxation time. Data were processed in MestReNova. Chemical shifts (δ) are given 
in parts per million (ppm) with coupling constants (J values) reported to the nearest 0.1 Hz.  
CD spectroscopy of PaHisGS and PaHisZ. Both proteins storage buffer was exchanged 
to a solution of 10 mM K2HPO4 pH 8.0, 10 mM KF by successive passages through 10,000 
MWCO Vivaspin centrifugal concentrators. CD spectra were acquired at 293 K in a Biologic 
MOS-500 spectrometer outfitted with a Peltier temperature controller in a 1-cm path length 
cuvette containing 0.5 mg mL-1 of either PaHisGS or PaHisZ. Blank spectra were recorded 
with the same buffer in the absence of protein and subtracted from the protein spectra. Protein 
Thermal denaturation was assessed by monitoring CD absorbance at either 208 nm for 
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PaHisGS or 222 nm for PaHisZ at varying temperatures (283 – 343 K with 2.5 K increments). 
All measurements for CD spectra and thermal denaturation were collected in duplicates. 
Kinetic and thermal denaturation data analysis. Kinetic data were analysed by the 
nonlinear regression function of SigmaPlot 13 (SPSS Inc.). Data points and error bars in graphs 
are represented as mean  standard error, and kinetic and equilibrium constants are presented 
as mean  fitting error. Initial rate data with varying concentrations of PaHisZ were fitted to 
eq 1. The concentration of PaATPPRT at any concentrations of PaHisGS and PaHisZ was 
calculated according to eq 2. Substrate saturation data were fitted to eq 3. Data for temperature-
dependence of the rates were fitted to eqs 4 and 5. In eqs 1 – 5, v is the initial rate, Vmax is the 
maximal velocity, G is the concentration of PaHisGS, Z is the concentration of PaHisZ, KD is 
the equilibrium dissociation constant, PaATPPRT is the concentration of PaHisGS–PaHisZ 
complex, S is the concentration of the varying substrate, kcat is the steady-state turnover number, 
KM is the Michaelis constant, ET is total enzyme concentration, T is the temperature in Kelvin, 
R is the gas constant, Ea is the energy of activation, and A the Arrhenius pre-exponential factor.  
𝑣 = 𝑉𝑚𝑎𝑥
(𝐺+𝑍+𝐾D)−√(𝐺+𝑍+𝐾D)2−4 𝐺 𝑍
2 𝐺
  eq 1 
𝑃𝑎𝐴𝑇𝑃𝑃𝑅𝑇 =
(𝐺+𝑍+𝐾D)−√(𝐺+𝑍+𝐾D)2−4 𝐺 𝑍
2 
  eq 2 
𝑣
𝐸T
=
𝑘cat 𝑆
𝐾M+𝑆
      eq 3 
𝑘cat = 𝐴 𝑒
−𝐸a
𝑅 𝑇       eq 4 
ln 𝑘cat =
−𝐸a
𝑅
(
1
𝑇
) +  ln 𝐴    eq 5 
Thermal denaturation data were fitted to eq 6. Here, FU is fraction unfolded, T is the 
temperature in K, Tm is the melting temperature, mT is the slope of the transition region,  mU 
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and bU are slope and intercept, respectively, of the unfolded baseline, and mF and bF, those of 
the folded baseline.47 
𝐹U =
(𝑚U 𝑇−𝑏U)−(𝑚F 𝑇−𝑏F)
1+(
𝑇
𝑇m
)
𝑚T + 𝑚F 𝑇 − 𝑏F  eq 6 
RESULTS AND DISCUSSION 
 Purification of PaATPPRT. PaHisGS and PaHisZ were purified to homogeneity via Ni-
affinity chromatography. No other bands were detected by Comassie Blue-stained SDS-PAGE 
(Figure S1). Typical yields were 8 mg and 10 mg of protein per gram of cells for PaHisGS and 
PaHisZ, respectively. As a result of His-tag removal with TEVP, both proteins have an 
additional residue, Gly, at their N-termini. ESI-MS analyses confirmed the molecular mass of 
each protein as 25,215 for PaHisGS and 43,082 for PaHisZ (Figure S2), closely matching their 
theoretical values of 25,213 and 43,085.  
 Crystal structure of PaATPPRT. The three-dimensional structure of PaATPPRT 
holoenzyme was solved and refined to 2.34-Å resolution, and refinement statistics are 
summarised in Table 1. Atomic coordinates were deposited in the Protein Data Bank under 
PDB ID 5M8H. As published with TmATPPRT12 and LlATPPRT,11 PaATPPRT is a hetero-
octamer consisting of four PaHisZ subunits in the centre flanked on each side by two PaHisGS 
subunits (Figure 1A and B). PaATPPRT crystals, in the P21 space group, had one hetero-
octamer per asymmetric unit. Even though ATP and histidine were present in the crystallisation 
mixture, no clear electron density was observed for either ligand. No electron density was 
observed for glutaraldehyde either, which suggests that the proteins may not have been cross-
linked in the crystal. 
 PaHisGS subunits. PaHisGS subunits overlay with slightly different root-mean-square 
deviation (rmsd) values depending on the subunit. For example, rmsd’s of 0.316, 0.177, and 
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0.384 Å result from overlaying subunit E with F, G, and H, respectively, over 208 C atoms.  
PaHisGS displays two domains, domain 1 and domain 2 (Figure 1C). The former includes 
residues 20 – 115 and 197 – 228, while the latter consists of residues 116 – 196. Residues 1 – 
19 are disordered and were excluded from the model. Domain 1 has six -strands split into two 
small antiparallel -sheets, 2-3 and 4-9-5, with 1 forming a three-stranded parallel 
sheet with 3 and 4. These -sheets are encircled by five -helices, 1, 2, 3, 7, and 8. 
Domain 2 includes a -strand core arranged in a three-stranded parallel -sheet (7-6-8), 
and a three-stranded antiparallel -sheet (8-5-9). This -strand core is sandwiched between 
4 on one side and 5 and 6 on the other. This domain arrangement is similar to those of 
TmHisGS
12 and LlHisGS,
11 and to the catalytic domains of HisGL.
8, 19  
Each pair of PaHisGS makes up a homodimer in which subunits interact in a head-to-
tail arrangement (Figure 1B). An interface score of 1 was calculated for this interaction, 
suggesting that it is responsible for homodimer formation. Scores of 0 indicate no interaction, 
while scores of 1 indicate that the interaction leads to complex formation.46 The interface 
covers approximately 1,200 Å2, representing 10.6% of the solvent accessible area. This 
encompasses thirty-one residues, mostly from 2, 2, 3, 7, and 5. Based on the crystal 
structure of PRPP-bound LlATPPR, the active site is expected to lie on a crevice between 
domains 1 and 2.21 The absence of electron density for ATP along with the absence of PRPP 
from the crystallisation mixture preclude a precise mapping of the PaATPPRT active-site 
interactions with substrates. Nevertheless, amino acid sequence alignment with HisGS 
orthologues using Clustal Omega shows that all PRPP-interacting residues and two ATP-
interacting ones are conserved in PaHisGS (Figure S3). 
PaHisZ subunits. Each subunit has a large N-terminal domain (NTD), encompassing 
residues 1 – 318, and a small C-terminal domain (CTD), residues 324 – 387, connected by a 
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loop (Figure 1D). NTD is comprised of a six-stranded antiparallel -sheet, 5-6-11-10-9-
7, flanked by two small -strands, 1 and 8, which run parallel to 5 and 7, respectively. 
This -sheet seats inside a bowl-like arrangement of nine -helices (1, 4-9, 11, 12) and 
two 310-helices (10 and 13). Helix 4 connects NTD with a small subdomain consisting of 
a three-stranded antiparallel -sheet, 2-4, and two small -helices, 2 and 3. The NTD is 
structurally similar to TmHisZ12 and LlHisZ.11 CTD consists of a three-stranded parallel -
sheet, 12-14, with 15 antiparallel to 14, and two -helices, 14 and 15. This CTD is 
absent in TmHisZ12 and LlHisZ,11 but present in HisRS.12 HisZ and HisRS are predicted to 
have diverged from a common ancestor.9 PaHisZ appears to have retained that CTD while 
TmHisZ and LlHisZ have lost it. 
Each pair of PaHisZ constitutes a homodimer in which subunits interact in a head-to-
tail arrangement (Figure 1A). A relatively low interface score of 0.23 was calculated for this 
interaction, in spite of involvement of both NTD and CTD.  The interface covers approximately 
3,300 Å2, representing 15.6% of the solvent accessible area. Interacting residues are found 
mainly in the regions 1-134 and 352-369. PaHisZ subunits overlay with slightly different rmsd 
values depending on the subunit. For example, rmsd’s of 0.798, 0.922, and 0.131 Å result from 
overlaying subunit A with B, C, and D, respectively. When the four PaHisZ chains are 
superimposed, the regions showing the largest differences involve 7-9, 10, and 11 in the 
NTD as well as 14, 15, 14, and 15 in the CTD (Figure S4). These regions are at opposing 
ends of the monomer and do not interact with other regions in the complex. 
PaHisGS-PaHisZ interface. The interaction between catalytic and regulatory subunits 
is shown in Figure 1E. The contact area is not as extensive as those of the homodimers. The 
interface between PaHisZ NTD and PaHisGS domain 1 covers approximately 860 Å
2, while 
that between PaHisZ NTD and PaHisGS domain 2 (of neighbouring subunit), 320 Å
2. 
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Calculated interface scores of only 0.03 and 0.01 for domains 1 and 2, respectively, suggests a 
relatively weak interaction between the two subunits. The interaction is stabilised by eight 
hydrogen bonds and three salt bridges for NTD-domain 1 and by four hydrogen bonds for 
NTD-domain 2. In addition, several hydrophobic residues (Leu107, Leu108, Leu202, Val204, 
Val207, Leu216, Leu220) contributed by PaHisGS are buried in this region.  
Cold-adaptations in PaATPPRT. Psychrophilic enzymes are suggested to be more 
flexible than their mesophilic counterparts as an adaptation to achieve high catalytic rates at 
low temperature, and this flexibility is purported to be more accentuated in the active site.23, 27 
Conversely, a compelling hypothesis recently proposed that cold-adaptation is achieved by 
increased flexibility at outer regions of enzymes, at the protein-solvent interface, while the core 
is significantly more rigid. In molecular dynamics simulations of cold-adapted trypsin, this 
variation in flexibility was assessed according to the magnitudes of thermal motion factors (B-
factors).48 The distribution of high and low B-factor regions throughout the catalytic and 
regulatory subunits in PaATPPRT (Figure 2A) is more complex. PaHisZ has a relatively 
“cold” core surrounded by “hot” outer regions (Figure 2B). However, the catalytic subunit is 
dominated by high B-factors with only small portions of intermediate flexibility (Figure 2C), 
even though the outer regions seem to be the “hottest” ones. Interestingly, residues expected to 
form the PRPP binding site are found in a relatively “hot” region of PaHisGS, while residues 
expected to interact with ATP are located on a comparatively more rigid region.      
 PaATPPRT KD values. Enzymatic activity by PaATPPRT is dependent on the 
concentration of PaHisZ (Figure 3A), even though the regulatory subunit has no catalytic 
activity. This indicates that PaHisZ binds to PaHisGS to form the PaATPPRT holoenzyme, 
activating PaHisGS catalysis, as expected.
11, 12 Fitting the data to eq 1 provided KD values over 
a range of temperatures (Table S1). The general trend suggests a decrease in affinity between 
PaHisZ and PaHisGS as the temperature increases (Figure 3B). Nevertheless, the total variation 
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in KD is small, with a minimum value of 4.7  0.8 M at 283 K and a maximum of 9.5  1.2 
M at 303 K. Knowledge of KD allows calculation, using eq 2, of PaATPPRT concentrations 
for any given concentrations of PaHisZ and PaHisGS, a requirement for determination of kcat 
in subsequent kinetic analyses. 
 Temperature-dependence of PaATPPRT kinetics. Psychrophilic enzymes are subjected 
to an intricate balance between protein stability and catalytic activity to ensure function at low 
temperature.23, 24, 27, 28 To investigate how temperature variation influences catalysis by 
PaATPPRT, steady-state kinetic constants were determined at several temperatures, and their 
values are summarized in Table S2. PaATPPRT followed Michaelis-Menten kinetics for both 
ATP (Figure 3C) and PRPP (Figure 3D). Values of kcat are 3-fold smaller and 3-fold larger, 
respectively, than those reported for LlATPPRT21 and for the homo-hexameric M. tuberculosis 
enzyme.3 PaATPPRT KM for PRPP is 14-fold, 46-fold, 63-fold, and 33-fold higher in 
comparison with those determined at similar temperatures for mesophilic ATPPRT’s from M. 
tuberculosis, C. jejuni, S. typhimurium, and L. lactis, respectively.3, 4, 14, 21 PaATPPRT KM for 
ATP is 6-fold, 17-fold, and 2-fold, higher in comparison with those determined at similar 
temperatures for mesophilic ATPPRT’s from M. tuberculosis, C. jejuni, and S. typhimurium, 
respectively.3, 4, 14 The exception is LlATPPRT KM for ATP, which is 1.5-fold lower than that 
for PaATPPRT.21 High KM is a common feature of cold-adapted enzymes.
24       
 PaATPPRT kcat increases with temperature between 283 – 303 K (Figure 3E), and data 
fitting to eq 4 resulted in an energy of activation (Ea) of 7.6  0.5 kcal mol-1. An Ea of 7.9  0.6 
kcal mol-1 was obtained by fitting the data to eq 5 in the more traditional Arrhenius plot (Figure 
3F). However, Arrhenius behaviour is sharply interrupted at 308 K (excluded from the fit) as 
the kcat decreases to a value similar to that found at 298 K (Figure 3E). Decrease in kcat at 
relatively mild temperatures is characteristic of psychrophilic enzymes, likely a consequence 
of portions of the protein beginning to unfold23, 24 (vide infra).  
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 PaHisGS catalysis in the absence of PaHisZ. PaHisGS displays catalytic activity 
without activation by PaHisZ (Figure 4). Moreover, while 1 mM histidine almost eliminates 
PaATPPRT-catalysed reaction, it has no effect on PaHisGS reaction (Figure 4). The latter 
observation also eliminates the possibility that enzymatic activity in the absence of PaHisZ 
might be due to some undetectable amount of contaminating E. coli ATPPRT (EcATPPRT), 
consisting of HisGL, in PaHisGS preparations, since just 200 M histidine would be enough to 
inhibit 95% of EcATPPRT.15 A similar observation of independent catalysis has been recently 
reported for LlHisGS.
22 
 In order to gather evidence in addition to the increase in UV absorbance at 290 nm1, 17 
that PaHisGS is catalysing the same reaction as PaATPPRT, both reactions were compared by 
31P-NMR spectroscopy (Figure 5). Spectra of both reactions, control, ATP, PRPP, and 
inorganic phosphate, along with assignment of chemical shifts, are shown in Figure S5. The 
spectra of reactions catalysed by PaHisGS (Figure 5A) and by PaATPPRT (Figure 5B) are 
essentially identical, and both differ from the control reaction which lacked PaHisGS (Figure 
5C). The most conspicuous difference, besides the increase in the inorganic phosphate peak at 
2.29 ppm, is the appearance of a peak at 3.30 ppm in the PaHisGS (Figure 5A, inset) and 
PaATPPRT (Figure 5B, inset) reactions, which is absent in the control (Figure 5C, inset). This 
peak corresponds to the phosphorus in the N1-5-phospho--D-ribose moiety of PR-ATP, while 
the same phosphorus has a chemical shift of 3.49 ppm in PRPP (Figure S5B). These 
observations confirm the products of PaHisGS-catalysed reaction are the same as those of the 
reaction catalysed by PaATPPRT. Combined, the results in this section qualitatively support 
those recently published for LlHisGS,
22 and indicate that the prevailing assumption that HisGS 
is catalytically inactive in the absence of HisZ11, 12 should be revised. 
 Temperature-dependence of PaHisGS kinetics. To explore the effect of temperature on 
PaHisGS catalytic rate, steady-state kinetic constants were determined at several temperatures, 
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and their values are summarized in Table S3. As observed with PaATPPRT, PaHisGS follows 
Michaelis-Menten kinetics for both ATP (Figure 6A) and PRPP (Figure 6B). Comparison 
between kcat values at corresponding temperatures for PaATPPRT and PaHisGS demonstrates 
that PaHisZ only modestly activates PaHisGS catalysis, as the holoenzyme kcat values are larger 
than those for PaHisGS by 4-fold at the lowest temperatures to just 2-fold at the highest ones. 
This is significantly different than what is found with LlATPPRT, in which LlHisZ confers 10-
fold activation as compared with LlHisGS alone.
22 Interestingly, PaHisGS KM values for both 
substrates are smaller in comparison with PaATPPRT, most markedly at the lowest 
temperatures which are likely to be closer to those experienced by P. arcticus in its natural 
environment.34 It is possible to hypothesise that the primary function of PaHisZ is to serve as 
a means of feedback inhibition by histidine, not to activate PaHisGS. 
PaHisGS kcat increases with temperature between 283 – 308 K (Figure 6C), and data 
fitting to eq 4 resulted in an Ea of 10.0  0.3 kcal mol-1, whereas an Ea of 10.5  0.3 kcal mol-1 
resulted from fitting the data to eq 5 in the Arrhenius plot (Figure 6D). Surprisingly, Arrhenius 
behaviour is obeyed up to 308 K, with PaHisGS departing from it only at 313 K (excluded from 
the fit) (Figure 6C). This points to PaHisZ rendering PaHisGS catalytic activity more 
thermolabile since PaATPPRT abandons Arrhenius behaviour by 308 K (Figure 3F). 
Thermal denaturation of PaHisGS and PaHisZ. To interrogate the possibility that 
PaHisZ tertiary structure is more thermolabile than that of PaHisGS, thermal denaturation of 
both proteins was assessed following their CD signal. Both PaHisGS and PaHisZ yielded CD 
spectra typical of folded proteins (Figure 6E).49 Thermal denaturation data were fitted to eq 6 
(Figure 6F) and yielded melting temperature (Tm) values of 316  1 K for PaHisGS and 312  
2 K for PaHisZ. In spite of the modest difference in Tm’s, the data are in qualitative correlation 
with the Arrhenius behaviour of PaHisGS and PaATPPRT kcat’s. It should be pointed out that 
the Tm’s might be affected if the proteins were in complex with each other. Unfortunately, all 
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attempts to measure the Tm for PaATPPRT led to protein precipitation as the temperature 
approached 313 K at the high protein concentrations needed to ensure that most of PaHisZ and 
PaHisGS were in complex. 
Two hypotheses could be invoked to explain the departure from Arrhenius behaviour 
by PaATPPRT. The simpler one would be that free PaHisZ (in molar excess to PaHisGS) starts 
to unfold at 308 K, which leads to dissociation of bound PaHisZ from PaATPPRT as the 
binding equilibrium is displaced. PaHisGS would then be the main contributor to kcat at 308 K, 
explaining the lower value. Nonetheless, this hypothesis is in disagreement with the 
PaATPPRT KD value at 308 K. The KD’s at 303 K and 308 K are the same within experimental 
error (Table S1). Hence there is no loss in affinity between the two proteins at 308 K to account 
for the decrease in PaATPPRT kcat.  
Another hypothesis is that PaATPPRT is mostly folded at 308 K, but there is a 
temperature-induced loosening of the interactions at PaHisGS-PaHisZ interfaces. This would 
not be enough to cause dissociation of the complex, as reflected by the unchanged KD at 308 
K. However, this loosening would be sufficient to interfere with activation of PaHisGS catalytic 
activity by the regulatory subunit, explaining the reduction in kcat. 
Utilising cold-adapted enzymes in biocatalysis reduces costs and emissions as heating 
is not required.30 As synthetic biology efforts towards histidine production in microbes depend 
on maintaining efficient catalysis while eliminating histidine feedback inhibition of ATPPRT,6 
PaHisGS provides an advantageous system to be explored.  
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Table 1. Crystallographic data and refinement statistics 
Parameter Value 
PDB ID 5M8H 
Wavelength (Å)  1.5418 
Resolution (Å)a 30.63 - 2.34 (2.38-2.34) 
Total No. reflections 390,223 
No. unique reflections 110,587 
  
Multiplicity 3.5 (2.4) 
Completeness (%) 97.6 (81.0) 
<I/sigI> 6.3 (0.9) 
Rmerge
b 0.135 (0.969) 
CC(1/2) 0.994 (0.366) 
Wilson B (Å2) 34.1 
Space group P21 
Unit cell parameters  
a (Å) 94.02 
b (Å) 146.73 
c (Å) 101.90 
α (°) 90.00 
β (°) 102.4 
γ (°) 90.00 
Refinement  
No. reflections (working set) 105092 
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No. reflections (Rfree test set) 5467 
Rwork/Rfree
c,d 0.23/0.27 
rmsd bond distances (Å) 0.010 
rmsd bond angles (°) 1.438 
No molecules per a.u. 4 each of HisG and HisZ 
Protein atoms 18229 
Ligands 37 
Water molecules 629 
Average B factor (Å2)  
Protein 50.14 
Ligands 57.76 
Waters 35.75 
Ramachandran plot  
Favoured (%) 97.4 
Allowed (%) 2.6 
Outliers  0 
aValues in parentheses are for the highest resolution shell. 
bRmerge =  ∑|I(hkl) – I| × 100/∑|I(hkl)|, where the average intensity I is taken over all symmetry 
equivalent measurements and I(hkl) is the measured intensity for a given observation. 
cRwork = ∑hkl||Fo(hkl)| – |Fc(hkl)||/∑hkl|Fo(hkl)|. 
dRfree = Rfactor for a test set of reflections (5%). 
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Scheme 1. ATP phosphoribosyltransferase-catalysed synthesis of N1-(5-phospho--D-
ribosyl)-ATP, the first step of histidine biosynthesis. 
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FIGURE LEGENDS 
Figure 1. Crystal structure of PaATPPRT. (A) Ribbon diagram of the hetero-octamer with 
four PaHisGS subunits (red and orange) and four PaHisZ subunits (green, blue, cyan, and 
yellow). (B) Top view of image shown in (A). Images in A and B created in PyMol. (C) Ribbon 
diagram of a PaHisGS monomer, with -helices in green and -strands in blue. (D) Ribbon 
diagram of a PaHisZ monomer, with -helices in green, -strands in blue, and 310-helices in 
beige. (E) PaHisZ NTD (ribbon diagram in green) and PaHisGS domain 1 (ribbon diagram in 
orange) and PaHisGS domain 2 of neighbouring subunit (ribbon diagram in red) interfaces. 
Side chains of residues participating in inter-subunit interactions are shown as stick models, 
with nitrogen in blue, oxygen in red, and carbon in either green (PaHisZ), orange (PaHisGS 
domain 1), and red (PaHisGS domain 2). Images generated in CCP4MG. 
Figure 2. B-factor distribution in (A) the PaATPPRT hetero-octamer, (B) PaHisZ monomer, 
and (C) PaHisGS monomer. Images generated in PyMol. 
Figure 3. Temperature studies of PaATPPRT. (A) Rate-dependence of PaATPPRT reaction 
on PaHisZ concentration at 283 K (pink), 288 K (red), 293 K (cyan), 298 K (blue), 303 K 
(green), and 308 K (grey). Lines represent data fitting to eq 1. (B) Temperature variation of 
PaHisGS-PaHisZ KD. (C) and (D) PaATPPRT saturation curves for ATP and PRPP, 
respectively, at 283 K (pink), 288 K (red), 293 K (cyan), 298 K (blue), 303 K (green), and 308 
K (grey). Lines represent data fitting to eq 3. (E) Deviation of PaATPPRT kcat from Arrhenius 
behaviour at 308 K. Line represents data fitting to eq 4, excluding data point at 308 K. (F) 
Linear Arrhenius plot of PaATPPRT kcat, excluding the data point at 308 K. Line represents 
data fitting to eq 5.  
Figure 4. PaHisGS catalysis in the absence of PaHisZ. (A) Time course of product formation 
for control without PaHisGS (red), control without PRPP (green), reaction with PaATPPRT at 
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1 M (blue), PaATPPRT reaction in the presence of 1 mM histidine (yellow), reaction with 
PaHisGS at 1.1 M (cyan) and 2.2 M (pink) without PaHisZ, and reaction with PaHisGS at 
2.2 M in the presence of 1 mM histidine without PaHisZ (grey). (B) Bar graph representation 
of the rates. Colour scheme the same as in A. 
Figure 5. 31P-NMR spectra of (A) PaHisGS reaction, (B) PaATPPRT reaction, and (C) control 
in the absence of PaHisGS. Insets in A and B are close-ups of the spectra between 4.0 and 3.0 
ppm showing the peak at 3.30 ppm, corresponding to the phosphorus in the N1-5-phospho--
D-ribose moiety of PR-ATP, which is missing in inset in C.  
Figure 6. Temperature studies of PaHisGS and PaHisZ. (A) and (B) PaHisGS saturation curves 
for ATP and PRPP, respectively, at 283 K (pink), 288 K (red), 293 K (cyan), 298 K (blue), 303 
K (green), 308 K (grey), and 313 K (black). Lines represent data fitting to eq 3. (C) Deviation 
of PaHisGS kcat from Arrhenius behaviour at 313 K. Line represents data fitting to eq 4, 
excluding data point at 313 K. (D) Linear Arrhenius plot of PaHisGS kcat, excluding the data 
point at 313 K. Line represents data fitting to eq 5. (E) CD spectra of PaHisGS (blue) and 
PaHisZ (pink). (F) Thermal denaturation curves for PaHisGS (blue) and PaHisZ (pink). Lines 
represent data fitting to eq 6. 
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